| Abstrakt: |
Researchers from Boston University have conducted a study on immunotherapies for locally aggressive cancers. The researchers emphasize the importance of improving surgical resection outcomes for these types of tumors in order to achieve better disease control and prevent metastasis. They discuss the potential benefits of intraoperative treatment using immunotherapies, which allow for direct access to the tumor microenvironment and minimize the risk of adverse effects on healthy tissues. The study concludes by summarizing current research progress, identifying areas for further exploration, and discussing future prospects for sustained remission. [Extracted from the article] |
